Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (351-360 of 662) with videos related to

Pageof 67
Sort By:
Blood|April 22, 2016
Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6Iris Z Uras, Gina J Walter, Ruth Scheicher, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2015
Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragmentsRaffaela Campana, Katharina Moritz, Katharina Marth, et al.
Blood|March 23, 2012
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligandViviane Ghanim, Harald Herrmann, Gerwin Heller, et al.
Leukemia Research Reports|March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HPeter Valent, Katharina Blatt, Gregor Eisenwort, et al.
Haematologica|April 26, 2019
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosisGeorg Greiner, Michael Gurbisz, Franz Ratzinger, et al.
Experimental Hematology|June 18, 2010
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816VAlexandra Böhm, Karoline Sonneck, Karoline V Gleixner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivityKarl J Aichberger, Irene Mittermann, Renate Reininger, et al.
Molecular Immunology|February 26, 2008
Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineeringKuan-Wei Chen, Gudrun Fuchs, Karoline Sonneck, et al.
Veterinary and Comparative Oncology|August 24, 2018
Comparative oncology: The paradigmatic example of canine and human mast cell neoplasmsMichael Willmann, Emir Hadzijusufovic, Olivier Hermine, et al.
Cancer|July 20, 2023
Risk as a pattern over time: Delineation of time-dependent risk factors in biological, psychological, and social variables in cancer patientsMatthias Knefel, Elisabeth L Zeilinger, Simone Lubowitzki, et al.
Pageof 67

Showing results (351-360 of 662) with videos related to

Sort By:
Pageof 67
Blood|April 22, 2016
Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6Iris Z Uras, Gina J Walter, Ruth Scheicher, et al.
The Journal of Allergy and Clinical Immunology|November 1, 2015
Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragmentsRaffaela Campana, Katharina Moritz, Katharina Marth, et al.
Blood|March 23, 2012
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligandViviane Ghanim, Harald Herrmann, Gerwin Heller, et al.
Leukemia Research Reports|March 6, 2014
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HPeter Valent, Katharina Blatt, Gregor Eisenwort, et al.
Haematologica|April 26, 2019
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosisGeorg Greiner, Michael Gurbisz, Franz Ratzinger, et al.
Experimental Hematology|June 18, 2010
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816VAlexandra Böhm, Karoline Sonneck, Karoline V Gleixner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivityKarl J Aichberger, Irene Mittermann, Renate Reininger, et al.
Molecular Immunology|February 26, 2008
Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineeringKuan-Wei Chen, Gudrun Fuchs, Karoline Sonneck, et al.
Veterinary and Comparative Oncology|August 24, 2018
Comparative oncology: The paradigmatic example of canine and human mast cell neoplasmsMichael Willmann, Emir Hadzijusufovic, Olivier Hermine, et al.
Cancer|July 20, 2023
Risk as a pattern over time: Delineation of time-dependent risk factors in biological, psychological, and social variables in cancer patientsMatthias Knefel, Elisabeth L Zeilinger, Simone Lubowitzki, et al.
Pageof 67